Wharton’s Jelly Mesenchymal Stem Cell Administration Improves Quality of Life and Self-Sufficiency in Children with Cerebral Palsy: Results from a Retrospective Study

Table 9

Adverse events reported by the patients’ parents.

Adverse event	(%)/ patients	(%)/ returned parental feedbacks
Dizziness	0	1 (4.3)
Drug dosage increased	1 (1.1)	0
Epileptic seizures more frequent (leading to discontinuation)	1 (1.1)	0
Emotional hypersensitivity	1 (1.1)	0
Engagement decreased	1 (1.1)	0
Fever	1 (1.1)	2 (8.7)
Headache	1 (1.1)	1 (1.1)
Hypersensitivity
Emotional	0	5 (21.7)
Sensual	0	2 (8.7)
Infections	0	2 (8.7)
Muscle tonus decreased	0
Skeletal		2 (8.7)
Smooth		1 (4.3)
Nausea and/or vomiting	2 (2.2)	2 (8.7)
Somnolence	0	1 (4.3)

Number of patients with AE divided by number of children with at least one available follow-up.